PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

204.63B

Vuru Grade

60.55/100

Current Price

$33.74
-0.23 (-0.68%)

Growth Price

$25.70
Overvalued by 23.82%

Stability Price

$11.98
Overvalued by 64.48%

Company Metrics

  • P/E 27.66
  • P/S 4.04
  • P/B 3.27
  • EPS 1.22
  • Cash ROIC 13.13%
  • Cash Ratio 0.79
  • Dividend 1.20 / 3.53 %
  • Avg. Vol. 37.83M
  • Shares 6.06B
  • Market Cap. 204.63B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Pfizer Inc. (NYSE:PFE) Acquires Anacor for $5 Bn, is Amgen Next?
LearnBonds - 6 hours ago
Pfizer Inc. (NYSE:PFE) has said that it has completed the process of acquiring Anacor Pharmaceuticals, Inc. As per the firm, the transaction terms provided each outstanding share of Anacor to be converted into the right to get $99.25 net in cash, i.e ...
Two Stocks within Analysts Review: Pfizer, Inc. (NYSE:PFE) , VIVUS, Inc ... - Street Updates
Read the Analyst's Study: Pfizer, Inc. (NYSE:PFE) , Bristol-Myers Squibb ... - Is stories
Pfizer Inc. (PFE) and Amgen, Inc. (AMGN) Nearing a Possible Mega-Deal?
TCC - Jun 23, 2016
Among the few named companies were Amgen, Inc. (NASDAQ:AMGN) and Pfizer Inc. (NYSE:PFE) that might seek a buyout or merger.
Healthcare Stocks in Frontline Brokers- Pfizer Inc. (NYSE:PFE), Gilead ...
Seneca Globe - 6 hours ago
Pfizer Inc. (NYSE:PFE) [Trend Analysis] considering as most desiring stocks in active trading lead, shares reduced following opening to traded at $33.97 with volume of 43.99 Million shares.
Eye Catching Stock: Pfizer Inc. (NYSE:PFE)
News Oracle - 5 hours ago
The Company fell -1.79% and finished at $33.97. The daily volume was measured at 43.95 million shares. The 52-week high of the share price is $36.46 and the 52-week low is $28.25.
Pfizer Inc. (NYSE:PFE) Signs Oracle Corporation (NYSE:ORCL) As Clinical Cloud ...
Market Exclusive - Jun 22, 2016
Pfizer Inc. (NYSE:PFE) has signed up for a suite of clinical cloud services from Oracle Corporation (NYSE:ORCL). The move further tightens the relation that the two companies have had for years.
Amgen, Inc. Fits Into Pfizer's Restructuring Plans Perfectly
Bidness ETC - Jun 24, 2016
Pfizer Inc. (NYSE:PFE) is currently considering acting on its plans to reorganize. The drugmaker announced that it would be restructuring itself to focus entirely on some of the key growth businesses, while trimming some of the units.
2 Sizzling Hot Biotechnology Stocks: Pfizer Inc. (PFE), Brookdale Senior ...
Zergwatch - Jun 23, 2016
Pfizer Inc. (PFE) ended last trading session with a change of -0.81 percent. It trades at an average volume of 38.05M shares versus 25.15M shares recorded at the end of last trading session.
Pfizer Inc. (NYSE:PFE) To Sink $200 Million In New Andover Facility
Market Exclusive - Jun 17, 2016
Pfizer Inc. (NYSE:PFE) is investing more than $200 million to build a new clinical manufacturing plant in Andover, Massachusetts.
HC Stocks Assessment: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK) - share market updates (press release)
Stocks With Perfect Match- Pfizer (NYSE:PFE), Moleculin Biotech, Inc. (NASDAQ ... - Seneca Globe
Pfizer Inc. (PFE) Price Target Lowered Along With Removal From Franchise Pick ...
TCC - Jun 20, 2016
Pfizer Inc. (NYSE:PFE) is one of the largest multinational pharmaceutical organizations. The headquarters of the company are located in Groton, Connecticut and is a listed company on the New York Stock Exchange (NYSE).
Pfizer Inc. (PFE): Jefferies Slashes Target Price over Waning GEPxit Drivers - Bidness ETC
Pfizer Inc. (NYSE:PFE) Analyst Opinion - Zergwatch
Pfizer Completes Anacor Acquisition
Benzinga - Jun 24, 2016
Pfizer Inc. (NYSE: PFE) revealed it completed its acquisition of Anacor Pharmaceuticals, Inc. According to the company, the transaction terms provided each outstanding share of Anacor to be converted into the right to get $99.25 net in cash, i.e ...
Pfizer Inc.: Pfizer Completes Acquisition of Anacor - The Wall Street Transcript
Market Analyst Estimation about twelve months Price Target: Pfizer, Inc. (NYSE ... - Is stories